Moreover, insulin use has been linked to an increased risk of new-onset AF in patients with T2DM, likely due to hypoglycemic episodes that trigger sympathetic activation and the more advanced stage of DM in these individuals [239]. The gene discussed is INS; the disease is type 2 diabetes mellitus.